Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Genetic locus annotated as a pseudogene (ENSG00000228335). Pseudogenes are nonfunctional DNA sequences that arose from ancestral genes but have lost the ability to encode functional proteins due to disruptive mutations. They can be processed (lack introns, formed by retrotransposition) or unprocessed (retain exon-intron structure). While most pseudogenes do not produce biologically active proteins, some may be transcribed and could play roles as regulatory non-coding RNAs or influence gene expression. However, no evidence suggests this specific pseudogene has such activity. It is not a protein-coding gene, receptor, enzyme, transporter, or any targetable molecule, nor is it associated with any known drugs or therapeutic applications. This entry represents a genetic pseudogene, not a classical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytokine induced protein 29 kDa pseudogene.